Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

AZN AstraZeneca PLC

78,415

0,295 (0,38%)

Zuletzt aktualisiert: 18:34:06

Verzögert um 15 Minuten

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Article too big to display. Click here to view on the SEC website

AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
Von Jun 2024 bis Jul 2024

Click Here for more AstraZeneca Charts.

AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
Von Jul 2023 bis Jul 2024

Click Here for more AstraZeneca Charts.

News AstraZeneca PLC

IMFINZI® (durvalumab) demonstrated statistically significant and clinically meaningful improvement in event-free survival and overall survival for muscle-invasive bladder cancer in NIAGARA Phase III trial
Dienstag 25 Juni 2024 (3 Wochen vor) • Business Wire

IMFINZI® (durvalumab) plus chemotherapy approved in the US for mismatch repair deficient advanced or recurrent endometrial cancer
Montag 17 Juni 2024 (4 Wochen vor) • Business Wire

CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of disease progression or death by 27% vs. standard of care in patients with untreated mantle cell lymphoma in ECHO Phase III trial
Sonntag 16 Juni 2024 (1 Monat vor) • Business Wire

FARXIGA approved in the US for the treatment of pediatric type-2 diabetes
Mittwoch 12 Juni 2024 (1 Monat vor) • Business Wire

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mittwoch 12 Juni 2024 (1 Monat vor) • Edgar (US Regulatory)

TAGRISSO® (osimertinib) granted Priority Review in the US for patients with unresectable, Stage III EGFR-mutated lung cancer
Montag 10 Juni 2024 (1 Monat vor) • Business Wire

I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer
Donnerstag 6 Juni 2024 (1 Monat vor) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Dienstag 4 Juni 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Dienstag 4 Juni 2024 (1 Monat vor) • Edgar (US Regulatory)

Economic Worries May Lead To Weakness On Wall Street
Dienstag 4 Juni 2024 (1 Monat vor) • IH Market News

AbelZeta announces clinical data showing preliminary anti-tumor activity for C-CAR031, an armored autologous GPC3 CAR-T, in patients with advanced hepatocellular carcinoma, at ASCO Annual Meeting 2024
Dienstag 4 Juni 2024 (1 Monat vor) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Montag 3 Juni 2024 (1 Monat vor) • Edgar (US Regulatory)

Weitere AstraZeneca PLC News-Artikel

Invesco QQQ Trust Series 1

Gold vs US Dollar

Deutsche Telekom

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen